PortfoliosLab logoPortfoliosLab logo
ISIN
US7711951043

Highlights

Market Cap
$348.31B
Enterprise Value
$389.02B
EPS (TTM)
CHF 2.82
PE Ratio
15.65
PEG Ratio
4.17
Total Revenue (TTM)
CHF 108.90B
Gross Profit (TTM)
CHF 79.49B
EBITDA (TTM)
CHF 37.44B
Year Range
$37.51 - $60.85
Target Price
$52.50
ROA (TTM)
18.57%
ROE (TTM)
55.77%
Avg. Volume (1M)
2M
Avg. Volume Value (1M)
$107.50M

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

RHHBY Performance Chart

Roche Holding AG ADR (RHHBY) is up 9.3% since the beginning of the year. At $55 per share, RHHBY is trading 10.2% below its 52-week high of $61. Investors who bought $1,000 worth of RHHBY shares 5 years ago would now be looking at an investment worth $1,339.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

Roche Holding AG ADR (RHHBY) has returned 9.27% so far this year and 45.09% over the past 12 months. Over the last ten years, RHHBY has returned 8.66% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.


Roche Holding AG ADR

1D
-1.09%
1M
3.07%
6M
-0.70%
YTD
9.27%
1Y
45.09%
3Y*
16.56%
5Y*
6.01%
10Y*
8.66%
ALL TIME*
8.68%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RHHBY Monthly Returns History

Based on dividend-adjusted daily data since Jan 2, 2001, RHHBY's average daily return is +0.04%, while the average monthly return is +0.87%. At this rate, an investment would double in approximately 6.7 years.

Historically, 56% of months were positive and 44% were negative. The best month was Mar 2009 with a return of +25.4%, while the worst month was Feb 2009 at -20.1%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 5 months.

On a daily basis, RHHBY closed higher 46% of trading days. The best single day was May 8, 2001 with a return of +13.6%, while the worst single day was Mar 17, 2003 at -13.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202610.04%4.93%-13.96%2.35%2.99%-2.00%6.47%9.27%
202512.53%6.34%1.93%-0.92%-1.15%1.14%-4.54%4.78%2.55%-3.37%18.39%7.82%52.86%
2024-3.01%-6.86%1.53%-6.58%7.34%8.31%16.84%4.49%-5.62%-2.85%-6.62%-3.75%0.23%
20230.00%-7.92%3.17%9.37%0.94%-3.51%1.31%-5.35%-7.37%-4.72%4.21%7.54%-4.02%
2022-6.00%-2.80%7.44%-6.54%-7.88%-1.95%-0.58%-2.48%0.45%1.77%-1.02%-4.33%-22.21%
2021-0.98%-5.32%0.61%0.37%7.49%7.38%2.70%4.06%-9.46%6.29%0.93%5.97%20.20%

Benchmark Metrics

Roche Holding AG ADR has an annualized alpha of 7.44%, beta of 0.48, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since January 02, 2001.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (61.75%) than losses (48.83%) - typical of diversified or defensive assets.
  • Beta of 0.48 may look defensive, but with R2 of 0.15 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
7.44%
Beta
0.48
0.15
Upside Capture
61.75%
Downside Capture
48.83%

Return for Risk

Risk / Return Rank

RHHBY ranks 83 for risk / return — above 83% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.


RHHBY Risk / Return Rank: 8383
Overall Rank
RHHBY Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
RHHBY Sortino Ratio Rank: 8585
Sortino Ratio Rank
RHHBY Omega Ratio Rank: 8383
Omega Ratio Rank
RHHBY Calmar Ratio Rank: 8282
Calmar Ratio Rank
RHHBY Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for Roche Holding AG ADR (RHHBY) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RHHBYBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

+0.16

Sortino ratioReturn per unit of downside risk

+0.41

Omega ratioGain probability vs. loss probability

1.29

1.25

+0.04

Calmar ratioReturn relative to maximum drawdown

2.32

2.00

+0.32

Martin ratioReturn relative to average drawdown

5.07

8.49

-3.42

Dividends

Dividend History

Roche Holding AG ADR provided a 2.83% dividend yield over the last twelve months, with an annual payout of $1.55 per share. The company has been increasing its dividends for 6 consecutive years.


1.50%2.00%2.50%3.00%3.50%4.00%$0.00$0.20$0.40$0.60$0.80$1.00$1.20$1.4020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$1.55$1.39$1.35$1.29$1.27$0.81$0.73$0.69$1.11$1.03$1.02$1.00

Dividend yield

2.83%2.69%3.87%3.55%3.23%1.57%1.66%1.70%3.58%3.25%3.57%2.91%

Monthly Dividends

The table displays the monthly dividend distributions for Roche Holding AG ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$1.55$0.00$0.00$0.00$0.00$1.55
2025$0.00$0.00$1.39$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.39
2024$0.00$0.00$1.35$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.35
2023$0.00$0.00$1.29$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.29
2022$0.00$0.00$1.27$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.27
2021$0.00$0.00$0.81$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.81

Dividend Yield & Payout


Dividend Yield

Roche Holding AG ADR has a dividend yield of 2.83%, which is quite average when compared to the overall market.

Payout Ratio

Roche Holding AG ADR has a payout ratio of 75.29%, which is quite average when compared to the overall market. This suggests that Roche Holding AG ADR strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Roche Holding AG ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Roche Holding AG ADR was 45.73%, occurring on Mar 2, 2009. Recovery took 567 trading sessions.

The current Roche Holding AG ADR drawdown is 6.98%.


Drawdown

Fall

Recovery

Underwater

Related event

-45.73%Mar 2009
1y 2d2y 3mo
3y 3moFeb 2008 - May 2011
Financial crisis2007–2009
-40.88%May 2024
2y 22d1y 6mo
3y 7moApr 2022 - Nov 2025
-40.69%Mar 2003
2y 2mo9mo 6d
2y 11moJan 2001 - Dec 2003
-27.32%Dec 2016
1y 6mo2y 2mo
3y 9moJun 2015 - Feb 2019
-20.28%Mar 2020
21d1mo 11d
2mo 2dFeb 2020 - Apr 2020
COVID crash2020

Drawdown Indicators


RHHBYBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-45.73%

-56.78%

+11.05%

Max Drawdown (1Y)

Largest decline over 1 year

-19.38%

-9.10%

-10.28%

Max Drawdown (3Y)

Largest decline over 3 years

-19.94%

-18.90%

-1.04%

Max Drawdown (5Y)

Largest decline over 5 years

-40.88%

-25.43%

-15.45%

Max Drawdown (10Y)

Largest decline over 10 years

-40.88%

-33.92%

-6.96%

Current Drawdown

Current decline from peak

-6.98%

-1.58%

-5.40%

Average Drawdown

Average peak-to-trough decline

-12.83%

-10.70%

-2.13%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.87%

2.14%

+6.73%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Roche Holding AG ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Roche Holding AG ADR is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for RHHBY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/E ratio of 15.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for RHHBY compared to other companies in the Drug Manufacturers - General industry. RHHBY currently has a PEG ratio of 4.2. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for RHHBY relative to other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/S ratio of 2.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for RHHBY in comparison with other companies in the Drug Manufacturers - General industry. Currently, RHHBY has a P/B value of 8.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with RHHBY

Add Roche Holding AG ADR to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with RHHBY